PortfoliosLab logoPortfoliosLab logo
FLGT vs. SMG
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

FLGT vs. SMG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fulgent Genetics, Inc. (FLGT) and The Scotts Miracle-Gro Company (SMG). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FLGT achieves a -30.80% return, which is significantly lower than SMG's 11.08% return.


FLGT

1D
1.91%
1M
6.25%
YTD
-30.80%
6M
-33.06%
1Y
-5.95%
3Y*
-21.12%
5Y*
-26.29%
10Y*

SMG

1D
1.24%
1M
7.32%
YTD
11.08%
6M
11.01%
1Y
4.51%
3Y*
8.00%
5Y*
-16.76%
10Y*
2.73%
*Multi-year figures are annualized to reflect compound growth (CAGR)

FLGT vs. SMG - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
FLGT
Fulgent Genetics, Inc.
-30.80%42.23%-36.11%-2.92%-70.39%93.07%303.88%306.94%-27.63%-62.14%
SMG
The Scotts Miracle-Gro Company
11.08%-8.01%8.28%36.92%-68.81%-18.03%96.18%77.05%-41.00%14.46%

Correlation

The correlation between FLGT and SMG is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.20

Correlation (3Y)
Calculated over the trailing 3-year period

0.25

Correlation (5Y)
Calculated over the trailing 5-year period

0.32

Correlation (All Time)
Calculated using the full available price history since Sep 29, 2016

0.21

The correlation between FLGT and SMG shifts across timeframes, from 0.20 (1 year) to 0.32 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

FLGT:

$561.42M

SMG:

$3.75B

EPS

FLGT:

-$2.40

SMG:

$1.90

PS Ratio

FLGT:

1.75

SMG:

1.09

Total Revenue (TTM)

FLGT:

$320.35M

SMG:

$3.39B

Gross Profit (TTM)

FLGT:

$121.99M

SMG:

$1.10B

EBITDA (TTM)

FLGT:

-$67.18M

SMG:

$493.90M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FLGT vs. SMG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FLGT
FLGT Risk / Return Rank: 3939
Overall Rank
FLGT Sharpe Ratio Rank: 3838
Sharpe Ratio Rank
FLGT Sortino Ratio Rank: 3838
Sortino Ratio Rank
FLGT Omega Ratio Rank: 4141
Omega Ratio Rank
FLGT Calmar Ratio Rank: 3939
Calmar Ratio Rank
FLGT Martin Ratio Rank: 3838
Martin Ratio Rank

SMG
SMG Risk / Return Rank: 4545
Overall Rank
SMG Sharpe Ratio Rank: 4747
Sharpe Ratio Rank
SMG Sortino Ratio Rank: 4141
Sortino Ratio Rank
SMG Omega Ratio Rank: 4141
Omega Ratio Rank
SMG Calmar Ratio Rank: 4747
Calmar Ratio Rank
SMG Martin Ratio Rank: 4646
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FLGT vs. SMG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fulgent Genetics, Inc. (FLGT) and The Scotts Miracle-Gro Company (SMG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FLGTSMGDifference
Sharpe ratioReturn per unit of total volatility

-0.24

Sortino ratioReturn per unit of downside risk

-0.14

Omega ratioGain probability vs. loss probability

1.05

1.05

0.00

Calmar ratioReturn relative to maximum drawdown

-0.11

0.19

-0.30

Martin ratioReturn relative to average drawdown

-0.21

0.34

-0.55

FLGT vs. SMG - Sharpe Ratio Comparison

The current FLGT Sharpe Ratio is -0.10, which is lower than the SMG Sharpe Ratio of 0.13. The chart below compares the historical Sharpe Ratios of FLGT and SMG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

FLGT vs. SMG - Drawdown Comparison

The maximum FLGT drawdown since its inception was -92.50%, which is greater than SMG's maximum drawdown of -83.55%. Use the drawdown chart below to compare losses from any high point for FLGT and SMG.


Loading charts...

Drawdown Indicators


FLGTSMGDifference

Max Drawdown

Largest peak-to-trough decline

-92.50%

-83.55%

-8.95%

Max Drawdown (1Y)

Largest decline over 1 year

-55.30%

-23.85%

-31.45%

Max Drawdown (3Y)

Largest decline over 3 years

-66.21%

-47.42%

-18.79%

Max Drawdown (5Y)

Largest decline over 5 years

-87.56%

-78.41%

-9.15%

Max Drawdown (10Y)

Largest decline over 10 years

-83.55%

Current Drawdown

Current decline from peak

-90.11%

-69.55%

-20.56%

Average Drawdown

Average peak-to-trough decline

-61.70%

-22.04%

-39.66%

Ulcer Index

Depth and duration of drawdowns from previous peaks

28.04%

13.31%

+14.73%

Volatility

FLGT vs. SMG - Volatility Comparison

Fulgent Genetics, Inc. (FLGT) has a higher volatility of 12.02% compared to The Scotts Miracle-Gro Company (SMG) at 10.03%. This indicates that FLGT's price experiences larger fluctuations and is considered to be riskier than SMG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FLGTSMGDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.02%

10.03%

+1.99%

Volatility (6M)

Calculated over the trailing 6-month period

56.70%

26.49%

+30.21%

Volatility (1Y)

Calculated over the trailing 1-year period

57.50%

34.25%

+23.25%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

51.11%

46.34%

+4.77%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

75.57%

40.43%

+35.14%

Dividends

FLGT vs. SMG - Dividend Comparison

FLGT has not paid dividends to shareholders, while SMG's dividend yield for the trailing twelve months is around 4.16%.


PositionTTM20252024202320222021202020192018201720162015
FLGT
Fulgent Genetics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SMG
The Scotts Miracle-Gro Company
4.16%4.52%3.98%4.14%5.43%1.59%3.72%2.13%3.51%1.93%2.03%2.85%

Financials

FLGT vs. SMG - Financials Comparison

This section allows you to compare key financial metrics between Fulgent Genetics, Inc. and The Scotts Miracle-Gro Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B2.00B20222023202420252026
71.14M
1.46B
(FLGT) Total Revenue
(SMG) Total Revenue
Values in USD except per share items

FLGT vs. SMG - Profitability Comparison

The chart below illustrates the profitability comparison between Fulgent Genetics, Inc. and The Scotts Miracle-Gro Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-20.0%0.0%20.0%40.0%60.0%80.0%20222023202420252026
27.4%
41.8%
Portfolio components
FLGT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Fulgent Genetics, Inc. reported a gross profit of 19.46M and revenue of 71.14M. Therefore, the gross margin over that period was 27.4%.

SMG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, The Scotts Miracle-Gro Company reported a gross profit of 610.50M and revenue of 1.46B. Therefore, the gross margin over that period was 41.8%.

FLGT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Fulgent Genetics, Inc. reported an operating income of -34.62M and revenue of 71.14M, resulting in an operating margin of -48.7%.

SMG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, The Scotts Miracle-Gro Company reported an operating income of 401.80M and revenue of 1.46B, resulting in an operating margin of 27.5%.

FLGT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Fulgent Genetics, Inc. reported a net income of -24.83M and revenue of 71.14M, resulting in a net margin of -34.9%.

SMG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, The Scotts Miracle-Gro Company reported a net income of 238.60M and revenue of 1.46B, resulting in a net margin of 16.4%.


Frequently Asked Questions


FLGT and SMG have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

FLGT has higher volatility (12.02%) compared to SMG (10.03%). In terms of maximum drawdown, FLGT dropped -92.50% vs SMG's -83.55%.

SMG currently has the higher Sharpe Ratio (0.13 vs -0.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for FLGT and SMG

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer